Therefore, we carried out a retrospective study to determine the clinicopathological significance of preoperative serum tumor markers (CEA, CA125 and CA15-3) in Chinese breast cancer patients as well as the relevance of these markers among different breast cancer subtypes. The gene discussed is MUC16; the disease is breast carcinoma.